Total Payments
$4,821
2024 Payments
$157.21
Companies
21
Transactions
299
Medicare Patients
235
Medicare Billing
$41,630
Payment Breakdown by Category
Food & Beverage$4,652 (96.5%)
Consulting$150.00 (3.1%)
Education$19.30 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,652 | 293 | 96.5% |
| Consulting Fee | $150.00 | 1 | 3.1% |
| Education | $19.30 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,236 | 52 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $840.86 | 85 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $505.04 | 42 | $0 (2020) |
| Neos Therapeutics, LP | $403.26 | 17 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $287.36 | 5 | $0 (2024) |
| Shire North American Group Inc | $232.48 | 20 | $0 (2019) |
| Lundbeck LLC | $209.81 | 13 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $194.44 | 12 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $188.65 | 11 | $0 (2020) |
| Allergan, Inc. | $172.28 | 11 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $157.21 | 3 | Teva Pharmaceuticals USA, Inc. ($138.23) |
| 2023 | $121.81 | 1 | Teva Pharmaceuticals USA, Inc. ($121.81) |
| 2022 | $102.21 | 1 | Neurocrine Biosciences, Inc. ($102.21) |
| 2021 | $289.16 | 6 | Alkermes, Inc. ($232.93) |
| 2020 | $384.26 | 18 | Alkermes, Inc. ($86.83) |
| 2019 | $984.04 | 72 | Sunovion Pharmaceuticals Inc. ($358.75) |
| 2018 | $962.70 | 80 | Alkermes, Inc. ($304.31) |
| 2017 | $1,820 | 118 | Alkermes, Inc. ($484.40) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $18.98 | General |
| Category: Narcoplepsy | ||||||
| 03/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Central Nervous System | ||||||
| 01/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $125.44 | General |
| Category: Central Nervous System | ||||||
| 09/26/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: Neurology | ||||||
| 09/28/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $102.21 | General |
| Category: Neuropsychiatry | ||||||
| 11/16/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $87.01 | General |
| Category: CNS | ||||||
| 09/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: CNS | ||||||
| 03/17/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEUROLOGY | ||||||
| 01/26/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $123.32 | General |
| Category: CNS | ||||||
| 11/11/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $86.83 | General |
| Category: CNS | ||||||
| 07/14/2020 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ADHD | ||||||
| 07/01/2020 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ADHD | ||||||
| 06/04/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2020 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| Category: PSYCHIATRY | ||||||
| 02/26/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/20/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: PSYCHIATRY | ||||||
| 02/18/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/13/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/13/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 01/30/2020 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: PSYCHIATRY | ||||||
| 01/21/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: OUD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 22 | 45 | $5,625 | $3,417 |
| 2022 | 3 | 58 | 132 | $15,220 | $9,448 |
| 2021 | 3 | 65 | 185 | $21,605 | $12,343 |
| 2020 | 3 | 90 | 265 | $30,245 | $16,423 |
Total Patients
235
Total Services
627
Medicare Billing
$41,630
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 45 | $5,625 | $3,417 | 60.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 76 | $9,500 | $6,482 | 68.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 20 | 32 | $2,720 | $1,584 | 58.2% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 11 | 24 | $3,000 | $1,382 | 46.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 111 | $13,875 | $8,616 | 62.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 16 | 36 | $4,500 | $2,089 | 46.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 17 | 38 | $3,230 | $1,638 | 50.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 152 | $19,000 | $10,629 | 55.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 32 | 72 | $6,120 | $3,470 | 56.7% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 18 | 41 | $5,125 | $2,323 | 45.3% |
About Dr. Richard Gestring, M.D
Dr. Richard Gestring, M.D is a Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1043530728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Gestring, M.D has received a total of $4,821 in payments from pharmaceutical and medical device companies, with $157.21 received in 2024. These payments were reported across 299 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,652).
As a Medicare-enrolled provider, Gestring has provided services to 235 Medicare beneficiaries, totaling 627 services with total Medicare billing of $41,630. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Saint Louis, MO
- Active Since 06/04/2010
- Last Updated 07/22/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1043530728
Products in Payments
- LATUDA (Drug) $840.86
- Vivitrol 380 mg (Drug) $524.16
- REXULTI (Drug) $457.52
- Adzenys XR-ODT (Drug) $403.26
- ARISTADA (Drug) $253.31
- ABILIFY MAINTENA (Drug) $197.61
- NUEDEXTA (Drug) $188.65
- VRAYLAR (Drug) $188.65
- INVEGA SUSTENNA (Drug) $171.50
- INGREZZA (Drug) $164.70
- Austedo XR (Drug) $138.23
- UZEDY (Drug) $121.81
- VYVANSE (Drug) $119.11
- Aristada 441 mg (Drug) $114.55
- MYDAYIS (Drug) $113.37
- VIVITROL (Drug) $106.54
- BELSOMRA (Drug) $96.53
- LYBALVI (Drug) $87.01
- Zubsolv (Drug) $78.22
- Lucemyra/Lofexidine (Drug) $39.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Louis
Dr. Mohd Malik, M.d, M.D
Psychiatry — Payments: $1.8M
Psychiatry $1.8M
Adam Sky, Md, MD
Psychiatry — Payments: $1.4M
Psychiatry $1.4M
Dr. Junaid Syed, M.d, M.D
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Michael Stotler, Md, MD
Psychiatry — Payments: $299,451
Psychiatry $299,451
Dr. Naji Chaaya Salloum, M.d, M.D
Psychiatry — Payments: $236,374
Psychiatry $236,374
Dr. Devnandini Rastogi, Md, MD
Psychiatry — Payments: $230,240
Psychiatry $230,240